Anbio Biotechnology (NASDAQ:NNNN) Sees Strong Trading Volume – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN) saw unusually-strong trading volume on Monday . Approximately 76,536 shares traded hands during trading, an increase of 44% from the previous session’s volume of 53,183 shares.The stock last traded at $7.6220 and had previously closed at $6.81.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings downgraded shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Anbio Biotechnology presently has an average rating of “Sell”.

Anbio Biotechnology Trading Up 13.2%

The company has a fifty day moving average of $11.38 and a two-hundred day moving average of $20.61.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.